Long-Term Results of Deep Brain Stimulation of the Mamillotegmental Fasciculus in Chronic Cluster Headache

• Published in: Stereotactic and functional neurosurgery Vol. 96; no. 4; p. 215
• Main Authors: Seijo-Fernandez, Fernando, Saiz, Antonio, Santamarta, Elena, Nader, Lydia, Alvarez-Vega, Marco Antonio, Lozano, Beatriz, Seijo, Elisa, Barcia, Juan A
• Format: Journal Article
• Language: English
• Published: Switzerland 01-01-2018
• Subjects: Adult; Cluster Headache - diagnostic imaging; Cluster Headache - physiopathology; Cluster Headache - therapy; Deep Brain Stimulation - methods; Diffusion Tensor Imaging; Female; Humans; Male; Middle Aged; Subthalamus - diagnostic imaging; Subthalamus - physiopathology; Treatment Outcome; Cluster headache; Hypothalamus; Deep brain stimulation; Mammillo-tegmental fasciculi; Neuromodulation
• ISSN: 1423-0372
• DOI: 10.1159/000489937

Deep brain stimulation (DBS) and the proper target for chronic cluster headache (CCH) are still subjects of controversy.
We present our long-term results of analysis of the target and its structural connectivity.
Fifteen patients with drug-resistant CCH underwent DBS in coordinates 4 mm lateral to the III ventricular wall and 2 mm behind and 5 mm below the intercommissural point. The clinical parameters recorded were the number of weekly attacks, pain intensity, and duration of the headache. Structural connectivity was studied using 3-T MR diffusion tensor imaging (DTI).
All of our patients improved from a mean of 39 attacks/week to 2; pain intensity decreased from 9 to 3 out of 10, and the mean cephalalgia duration decreased from 53 to 8 min. The mean stereotactic coordinates of the effective contact location were 6.1 mm lateral to the midcommissural point and 1.2 mm behind and 4.0 mm below the intercommissural point. DTI analysis showed that this target was connected to tracts and nuclei of the posterior mesencephalic tegmentum, specifically the dorsal longitudinal and mamillotegmental fasciculi.
Our data showed DBS to be a safe and useful procedure for the treatment of drug-resistant CCH; the rate of improvement was higher than those found in other series. Although these are promising results, larger series targeting those fasciculi with a longer follow-up are needed.